Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics
Cell Chemical Biology · 2024-02 · 31 (2) · 207-220.e11
DOI: 10.1016/j.chembiol.2023.08.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Chemical Biology, 2024-02. Verfasst von Sujata Chakraborty und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Washington, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: src-Family Kinases, Adenosine Triphosphate. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHGRI NIH HHS, National Human Genome Research Institute.
Abstract (Originalsprache)
Kinase inhibitors are effective cancer therapies, but resistance often limits clinical efficacy. Despite the cataloging of numerous resistance mutations, our understanding of kinase inhibitor resistance is still incomplete. Here, we comprehensively profiled the resistance of ∼3,500 Src tyrosine kinase mutants to four different ATP-competitive inhibitors. We found that ATP-competitive inhibitor resistance mutations are distributed throughout Src's catalytic domain. In addition to inhibitor contact residues, residues that participate in regulating Src's phosphotransferase activity were prone to the development of resistance. Unexpectedly, we found that a resistance-prone cluster of residues located on the top face of the N-terminal lobe of Src's catalytic domain contributes to autoinhibition by reducing catalytic domain dynamics, and mutations in this cluster led to resistance by lowering inhibitor affinity and promoting kinase hyperactivation. Together, our studies demonstrate how drug resistance profiling can be used to define potential resistance pathways and uncover new mechanisms of kinase regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Washington, Seattle, WA 98195, USA.
- Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Molecular and Cellular Biology, University of Washington, Seattle, WA 98195, USA.
- Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
- Department of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
- Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering, University of Washington, Seattle, WA 98195, USA. Electronic address: dfowler@uw.edu.
- Department of Chemistry, University of Washington, Seattle, WA 98195, USA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. Electronic address: djmaly@uw.edu.
Förderung
- NIGMS NIH HHS
- NHGRI NIH HHS
- National Human Genome Research Institute
- National Institute of General Medical Sciences
Zitieren
APA
Chakraborty, S., Ahler, E., Simon, J. J., Fang, L., Potter, Z. E., Sitko, K. A., Stephany, J. J., Guttman, M., Fowler, D. M., & Maly, D. J. (2024). Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics. Cell Chemical Biology, 31(2), 207-220.e11. https://doi.org/10.1016/j.chembiol.2023.08.005
Vancouver
Chakraborty S, Ahler E, Simon JJ, Fang L, Potter ZE, Sitko KA, et al. Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics. Cell Chemical Biology. 2024;31(2):207-220.e11. doi:10.1016/j.chembiol.2023.08.005
BibTeX
@article{Chakraborty2024,
author = {Chakraborty, Sujata and Ahler, Ethan and Simon, Jessica J and Fang, Linglan and Potter, Zachary E and Sitko, Katherine A and Stephany, Jason J and Guttman, Miklos and Fowler, Douglas M and Maly, Dustin J},
title = {Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics},
journal = {Cell Chemical Biology},
year = {2024},
volume = {31},
number = {2},
pages = {207--220.e11},
doi = {10.1016/j.chembiol.2023.08.005}
}
EUVIMED